HRP20110534T1 - Novi spojevi i njihova uporaba - Google Patents
Novi spojevi i njihova uporaba Download PDFInfo
- Publication number
- HRP20110534T1 HRP20110534T1 HR20110534T HRP20110534T HRP20110534T1 HR P20110534 T1 HRP20110534 T1 HR P20110534T1 HR 20110534 T HR20110534 T HR 20110534T HR P20110534 T HRP20110534 T HR P20110534T HR P20110534 T1 HRP20110534 T1 HR P20110534T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound according
- compound
- pharmaceutical composition
- formula
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 17
- 150000001450 anions Chemical class 0.000 claims abstract 2
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 2
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 2
- 241001529453 unidentified herpesvirus Species 0.000 claims 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0600134A SE529777C2 (sv) | 2006-01-23 | 2006-01-23 | Nya föreningar och användning därav |
PCT/SE2007/050033 WO2007084073A1 (fr) | 2006-01-23 | 2007-01-22 | Nouveaux composés et applications |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20110534T1 true HRP20110534T1 (hr) | 2011-09-30 |
Family
ID=38287919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20110534T HRP20110534T1 (hr) | 2006-01-23 | 2011-07-18 | Novi spojevi i njihova uporaba |
Country Status (24)
Country | Link |
---|---|
US (1) | US8076341B2 (fr) |
EP (1) | EP1976853B1 (fr) |
JP (1) | JP5190379B2 (fr) |
CN (1) | CN101374845B (fr) |
AR (1) | AR059149A1 (fr) |
AT (1) | ATE506365T1 (fr) |
AU (1) | AU2007206092B2 (fr) |
BR (1) | BRPI0707203C1 (fr) |
CA (1) | CA2637417C (fr) |
CY (1) | CY1112596T1 (fr) |
DE (1) | DE602007014008D1 (fr) |
DK (1) | DK1976853T3 (fr) |
ES (1) | ES2365423T3 (fr) |
HR (1) | HRP20110534T1 (fr) |
IL (1) | IL192820A (fr) |
NZ (1) | NZ569840A (fr) |
PL (1) | PL1976853T3 (fr) |
PT (1) | PT1976853E (fr) |
RS (1) | RS51933B (fr) |
RU (1) | RU2437887C2 (fr) |
SE (1) | SE529777C2 (fr) |
SI (1) | SI1976853T1 (fr) |
WO (1) | WO2007084073A1 (fr) |
ZA (1) | ZA200806315B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602008001795D1 (de) | 2008-04-30 | 2010-08-26 | Univ Duisburg Essen | IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel |
EP2489354A1 (fr) | 2011-02-18 | 2012-08-22 | Vironova AB | Formulation pharmaceutique de B220 pour le traitement topique de l'herpès |
CN105061432B (zh) * | 2015-07-16 | 2017-09-29 | 河北大学 | 6H‑吲哚[2,3‑b]喹喔啉衍生物、药物组合物及其制备和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8600261D0 (sv) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | Indolokinoxaliner med substituenter i 6-position som innehaller cykliska grupper |
SE8600260D0 (sv) * | 1986-01-21 | 1986-01-21 | Lundblad Leif | Substituerade indolokinoxaliner |
SE527639C2 (sv) * | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkylsubstituerade indolokinoxaliner |
-
2006
- 2006-01-23 SE SE0600134A patent/SE529777C2/sv not_active IP Right Cessation
-
2007
- 2007-01-22 CA CA2637417A patent/CA2637417C/fr not_active Expired - Fee Related
- 2007-01-22 JP JP2008551228A patent/JP5190379B2/ja not_active Expired - Fee Related
- 2007-01-22 PL PL07709426T patent/PL1976853T3/pl unknown
- 2007-01-22 NZ NZ569840A patent/NZ569840A/en not_active IP Right Cessation
- 2007-01-22 BR BRPI0707203A patent/BRPI0707203C1/pt not_active IP Right Cessation
- 2007-01-22 AT AT07709426T patent/ATE506365T1/de active
- 2007-01-22 DE DE602007014008T patent/DE602007014008D1/de active Active
- 2007-01-22 AU AU2007206092A patent/AU2007206092B2/en not_active Ceased
- 2007-01-22 SI SI200730657T patent/SI1976853T1/sl unknown
- 2007-01-22 RU RU2008134509/04A patent/RU2437887C2/ru active
- 2007-01-22 AR ARP070100274A patent/AR059149A1/es not_active Application Discontinuation
- 2007-01-22 CN CN2007800028861A patent/CN101374845B/zh not_active Expired - Fee Related
- 2007-01-22 WO PCT/SE2007/050033 patent/WO2007084073A1/fr active Application Filing
- 2007-01-22 PT PT07709426T patent/PT1976853E/pt unknown
- 2007-01-22 RS RS20110304A patent/RS51933B/en unknown
- 2007-01-22 US US12/161,081 patent/US8076341B2/en not_active Expired - Fee Related
- 2007-01-22 ES ES07709426T patent/ES2365423T3/es active Active
- 2007-01-22 EP EP07709426A patent/EP1976853B1/fr active Active
- 2007-01-22 ZA ZA200806315A patent/ZA200806315B/xx unknown
- 2007-01-22 DK DK07709426.6T patent/DK1976853T3/da active
-
2008
- 2008-07-15 IL IL192820A patent/IL192820A/en active IP Right Grant
-
2011
- 2011-07-18 CY CY20111100698T patent/CY1112596T1/el unknown
- 2011-07-18 HR HR20110534T patent/HRP20110534T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111848615B (zh) | 吡啶酮衍生物及包含其的抗流感病毒药物组合物 | |
HRP20230281T1 (hr) | Postupak sinteze | |
ES2228557T3 (es) | Aminobenzofenonas con inhibidores de la il-1beta y tnf-alfa. | |
JP6987859B2 (ja) | Magl阻害剤 | |
JP3478852B2 (ja) | ジフェニルオキサゾール、チアゾールおよびイミダゾールのアデノシン再吸収阻害誘導体 | |
MX2015002697A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b. | |
EP2693876B1 (fr) | Réactifs de méthylformyle substitué et procédé d'utilisation de ceux-ci pour modifier des propriétés physicochimiques et/ou pharmacocinétiques de composés | |
JP6621329B2 (ja) | 新規化合物、それらの合成及びそれらの使用 | |
HRP20170695T1 (hr) | Fenil-3-aza-biciklo[3.1.0]heks-3-il-metanoni i njihova uporaba u obliku lijeka | |
HRP20170621T1 (hr) | Postupak za pripremanje derivata piperazinil i diazepanil benzamida | |
UY31507A1 (es) | Derivados de piridina activadores de guanilato ciclasa soluble | |
ES2228555T3 (es) | Aminobenzofenonas con inhibidores de la il-1beta y tnf-alfa. | |
RS51545B (en) | THIAZOL PIRAZOLOPIRAMIDINS AS ANTAGONISTS OF CRF1 RECEPTORS | |
HRP20110534T1 (hr) | Novi spojevi i njihova uporaba | |
RS53081B (en) | THIAZOLOPYRIDIN-2-ILOXY-PHENYL I AMINI THIAZOLOPYRIDIN-2-ILOXY-PHENYL KAO MODULATOR LEUKOTRIEN A4 HYDROLAZE | |
US20140335326A1 (en) | Photo-reactive binder | |
SI1831186T1 (sl) | Postopek za sintezo valsartana | |
CN106879256A (zh) | 2‑氨基‑苯并咪唑衍生物及其作为5‑脂氧合酶和/或前列腺素e合成酶抑制剂的应用 | |
AU2013215549B2 (en) | Novel morpholinyl derivatives useful as MOGAT-2 inhibitors | |
ES2614997T3 (es) | Compuestos reguladores del crecimiento vegetal | |
WO2017134617A1 (fr) | Procédé de préparation de dasatinib amorphe | |
DE602004017894D1 (de) | Biphenylderivate, die sich als rar-rezeptor-aktivierende liganden eignen, verfahren zu deren herstellung und deren verwendung in der humanmedizin und in kosmetika | |
WO2011065420A1 (fr) | Procédé de fabrication d'un dérivé de 1-méthyl-1h-benzimidazole substitué en 6 et intermédiaire de fabrication issu de ce procédé | |
CA2597300A1 (fr) | Nouveaux derives d'acide betulinique | |
PL207487B1 (pl) | Pochodna aminobenzofenonu o wzorze I, jej zastosowanie i kompozycja zawierająca ten związek |